Hideaki Kakeya Selected Research

lucilactaene

5/2005

Determination by asymmetric total synthesis of the absolute configuration of lucilactaene, a cell-cycle inhibitor in p53-transfected cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hideaki Kakeya Research Topics

Disease

26	Neoplasms (Cancer) 10/2021 - 01/2003
5	Hypoxia (Hypoxemia) 10/2021 - 04/2015
5	Heart Failure 07/2021 - 01/2011
3	Cardiomegaly (Heart Hypertrophy) 07/2021 - 04/2018
3	Fibrosis (Cirrhosis) 01/2020 - 01/2011
3	Myocardial Infarction 01/2014 - 01/2011
2	Multiple Sclerosis 01/2022 - 01/2021
2	Colonic Neoplasms (Colon Cancer) 05/2020 - 01/2017
2	Hypertrophy 01/2020 - 04/2018
2	Neoplasm Metastasis (Metastasis) 01/2015 - 09/2008
2	Breast Neoplasms (Breast Cancer) 03/2009 - 04/2008
1	Hypertension (High Blood Pressure) 07/2021
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 07/2021
1	Inflammation (Inflammations) 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Disease Progression 01/2020
1	Glucose Intolerance 01/2019
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019
1	Hemolysis 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Atherosclerosis 01/2016
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2016
1	Sarcoma (Soft Tissue Sarcoma) 04/2015
1	Infarction (Infarctions) 01/2011
1	Carcinoma (Carcinomatosis) 04/2008
1	Acquired Immunodeficiency Syndrome (AIDS) 05/2006
1	Infections 05/2006
1	Neuroblastoma 09/2004

Drug/Important Bio-Agent (IBA)

10	CurcuminIBA 01/2022 - 01/2011
5	Hypoxia-Inducible Factor 1IBA 10/2021 - 01/2015
4	Histone Acetyltransferases (Histone Acetyltransferase)IBA 07/2021 - 01/2011
4	Pharmaceutical PreparationsIBA 01/2021 - 05/2006
4	Proteins (Proteins, Gene)FDA Link 10/2013 - 04/2008
3	GlucuronidesIBA 01/2022 - 05/2020
3	Biological ProductsIBA 01/2019 - 07/2004
2	Oxygen (Dioxygen)IBA 10/2021 - 01/2008
2	LuciferasesIBA 01/2021 - 04/2015
2	Amino Acids FDA Link 01/2020 - 01/2006
2	oxidized low density lipoproteinIBA 01/2019 - 01/2016
2	SolventsIBA 01/2014 - 01/2011
2	PerforinIBA 10/2005 - 03/2004
2	Fas Ligand Protein (Fas Ligand)IBA 10/2005 - 03/2004
2	phosmidosineIBA 10/2004 - 01/2003
2	Angiogenesis InhibitorsIBA 07/2004 - 07/2004
1	SaltsIBA 07/2021
1	NF-kappa B (NF-kB)IBA 05/2020
1	ProdrugsIBA 05/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2020
1	CateninsIBA 01/2020
1	EnzymesIBA 01/2020
1	Histones (Histone)IBA 01/2020
1	HydrolasesIBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	AcetyltransferasesIBA 01/2020
1	UbiquitinIBA 01/2020
1	Serine (L-Serine)FDA Link 01/2020
1	1,5- bis(3,5- bis(methoxymethoxy)phenyl)penta- 1,4- dien- 3- oneIBA 01/2020
1	verucopeptinIBA 10/2019
1	AdipokinesIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Phenol (Carbolic Acid)FDA Link 04/2018
1	DiarylheptanoidsIBA 04/2018
1	AntigensIBA 10/2016
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2016
1	Lipoproteins (Lipoprotein)IBA 01/2016
1	Carbonic Anhydrase IXIBA 04/2015
1	Ubiquitin CIBA 01/2015
1	Deubiquitinating EnzymesIBA 01/2015
1	HeterochromatinIBA 10/2013
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2011
1	Enalapril FDA LinkGeneric 01/2011
1	MycotoxinsIBA 03/2009
1	tryptoquivalineIBA 03/2009
1	DiketopiperazinesIBA 03/2009
1	azaspireneIBA 09/2008
1	Antineoplastic Agents (Antineoplastics)IBA 04/2008
1	tryprostatin AIBA 04/2008
1	tryprostatin BIBA 04/2008
1	Etoposide (VP 16)FDA LinkGeneric 04/2008
1	Antimitotic AgentsIBA 04/2008
1	fumagillinIBA 05/2006
1	lucilactaeneIBA 05/2005
1	Peptides (Polypeptides)IBA 10/2004
1	Adenosine Monophosphate (AMP)IBA 10/2004
1	epolactaeneIBA 09/2004
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2004
1	Granzymes (Granzyme)IBA 03/2004

Therapy/Procedure

10	Drug Therapy (Chemotherapy) 10/2021 - 07/2004
7	Therapeutics 10/2021 - 07/2004
1	Intravenous Injections 01/2017